MedPath

The Effect of Task-oriented EMG-triggered ES on Upper Limb Motor Function in Hemiplegic Cerebral Palsy

Completed
Conditions
Cerebral Palsy, Spastic
Interventions
Other: electromyography-triggered electrical stimulation
Registration Number
NCT04394819
Lead Sponsor
nihal tezel
Brief Summary

The purpose of our study; to investigate the effects of EMG-induced ES treatment on hand functions, muscle strength, and quality of life in patients with hemiplegic CP.

Detailed Description

Upper limb spasticity greatly affects the hand functions of patients with cerebral palsy (CP) and impairs quality of life. The most important goal in rehabilitation; despite the existing deficiencies, the highest level of functional independence of the patient is to increase the quality of life. EMG-triggered biofeedback electrical stimulation (EMG-triggered-BF-ES) increases the patient's active participation and motivation in rehabilitation, creates visual or auditory BF, provides muscle reeducation, decreases spasticity, prevents atrophies and increases joint mobility and increases muscle functionality by increasing the patient's functionality. There are areas of use the EMG-triggered-BF-ES such as cerebrovascular disease (CVO), spinal cord injury, and CP. When the literature is examined; studies were found to be few, and no study evaluating the upper extremity was found in children with CP. The purpose of our study is the investigation of the effects of EMG-triggered-BF-ES treatment applied on hand functions, muscle strength, and quality of life in patients with CP.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • having a diagnosis of CP
  • age between 4 and 18 year
  • at least 10° of the active wrist and finger extension in the affected limb but less than normal
  • upper limb spasticity (shoulder, elbow, wrist, and fingers) less than or equal to grade 2 according to the modified Ashworth scale (MAS)
  • should be able to receive command
Exclusion Criteria
  • Mental retardation
  • Passive range of motion (ROM) limitation in the upper extremity
  • Sensory impairment in the upper extremity
  • The visual and auditory deficit in the upper extremity
  • MAS is more than 3.
  • Botulinum toxin application to the upper limb in the last 6 months
  • Any surgical application to the upper limb in the last 6 months

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
experimental and control groupselectromyography-triggered electrical stimulationTask-oriented EMG-triggered ES treatment will be applied to the experimental group 2 days a week for 5 weeks and will continue with conventional physiotherapy. The control group will only continue conventional physiotherapy treatment.
Primary Outcome Measures
NameTimeMethod
Action Research Arm Test (ARAT)within 3 months

The ARAT consists of four subscales: grasp, grip, pinch, and gross movement. It contains 19 tasks, and each task is scored on a four-point scale (0, can perform no part of the test; 1, performs test partially; 2, completes test but takes abnormally long time or has great difficulty; and 3, performs test normally).

The Cerebral Palsy Quality of Life Questionnaire (CPQoL)within 3 months

Health condition-specific questionnaire designed for measuring QOL in children with cerebral palsy (CP). It consists of a caregiver and a child survey. It is used for the evaluation of Sp cases between the ages of 4-12.

Secondary Outcome Measures
NameTimeMethod
nine hole peg test (9-HPT)at the beginning, at the 5th week, and at the 3rd-month visit.

9-HPT test is a standardized,quantitative assesment used to measure finger dexterity.

hydraulic hand dynamometerat the beginning, at the 5th week, and at the 3rd-month visit.

Patients were encouraged to press as firmly as possible. Three consecutive measurements were performed. The average of the measurements was recorded in kilogram (kg).

Trial Locations

Locations (1)

DiskapiYBERH

🇹🇷

Ankara, Turkey

© Copyright 2025. All Rights Reserved by MedPath